Introduction:Basic information about CAS 728033-96-3|OSI-930, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | OSI-930 |
|---|
| CAS Number | 728033-96-3 | Molecular Weight | 443.441 |
|---|
| Density | 1.5±0.1 g/cm3 | Boiling Point | 517.4±50.0 °C at 760 mmHg |
|---|
| Molecular Formula | C22H16F3N3O2S | Melting Point | / |
|---|
| MSDS | / | Flash Point | 266.7±30.1 °C |
|---|
Names
| Name | 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide |
|---|
| Synonym | More Synonyms |
|---|
OSI-930 BiologicalActivity
| Description | OSI-930 is a potent inhibitor of Kit, KDR and CSF-1R with IC50 of 80 nM, 9 nM and 15 nM, respectively; also potent to Flt-1, c-Raf and Lck and low activity against PDGFRα/β, Flt-3 and Abl.IC50 value: 9 nM(VEGFR2); 15 nM(CSF1R); 80 nM (Kit activated) [1]Target: VEGFR2/Kit/CSF1Rin vitro: OSI-930 inhibits the cell proliferation in the HMC-1 cell line with IC50 of 14 nM without significant effect on growth of the COLO-205 cell line that does not express a constitutively active mutant receptor tyrosine kinase. Moreover, OSI-930 also induces apoptosis in HMC-1 cell line with EC50 of 34 nM [1]. A recent study shows that OSI-930 inactivates purified, recombinant cytochrome P450 (P450) 3A4 with a Ki of 24 μM in a time- and concentration-dependent mode [2].in vivo: OSI-930, administrated at the maximally efficacious dose of 200 mg/kg by oral gavage, exhibits potent antitumor activity in a broad range of preclinical xenograft models including HMC-1, NCI-SNU-5, COLO-205 and U251 xenograft models [1]. |
|---|
| Related Catalog | Signaling Pathways >>Protein Tyrosine Kinase/RTK >>c-FmsSignaling Pathways >>Protein Tyrosine Kinase/RTK >>c-KitResearch Areas >>Cancer |
|---|
| References | [1]. Garton AJ, et al. OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft models. Cancer Res. 2006, 66(2):1015-1024. [2]. Lin HL, et al. Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug. Drug Metab Dispos. 2011, 39(2), 345-350. |
|---|
Chemical & Physical Properties
| Density | 1.5±0.1 g/cm3 |
|---|
| Boiling Point | 517.4±50.0 °C at 760 mmHg |
|---|
| Molecular Formula | C22H16F3N3O2S |
|---|
| Molecular Weight | 443.441 |
|---|
| Flash Point | 266.7±30.1 °C |
|---|
| Exact Mass | 443.091522 |
|---|
| PSA | 91.49000 |
|---|
| LogP | 5.10 |
|---|
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
|---|
| Index of Refraction | 1.687 |
|---|
| InChIKey | FGTCROZDHDSNIO-UHFFFAOYSA-N |
|---|
| SMILES | O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12 |
|---|
| Storage condition | -20℃ |
|---|
Synonyms
| 3-[(quinolin-4-ylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide |
| N-(4-trifluoromethoxyphenyl) 3-[(quinolin-4-ylmethyl)amino]thiophene-2-carboxamide |
| 3-[(4-Quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]-2-thiophenecarboxamide |
| OSI-930 |
| 2-Thiophenecarboxamide, 3-[(4-quinolinylmethyl)amino]-N-[4-(trifluoromethoxy)phenyl]- |
| S1220_Selleck |